Knockdown of lncRNA ZNRD1‐AS1 inhibits progression of bladder cancer by regulating miR‐194 and ZEB1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Knockdown of lncRNA ZNRD1‐AS1 inhibits progression of bladder cancer by regulating miR‐194 and ZEB1

Published:2020-08-30 Issue:20 Volume:9 Page:7695-7705
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gao Zhixiang¹^ORCID,Li Shidong¹^ORCID,Zhou Xufeng¹^ORCID,Li Huali¹^ORCID,He Shasha¹^ORCID

Affiliation:

1. Department of Imaging And Magnetic Response the Luoyang Central Hospital Affiliated to Zhengzhou University Luoyang China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3373

Reference36 articles.

1. Bladder cancer

2. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

3. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

4. mRNA, microRNA and lncRNA as novel bladder tumor markers

5. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of long non-coding RNAs (lncRNAs) in gastric cancer metastasis: A comprehensive review;Pathology - Research and Practice;2024-10

2. miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers;Cellular Signalling;2023-12

3. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies;Biomedicine & Pharmacotherapy;2023-09

4. lncRNA-mediated ceRNA network in bladder cancer;Non-coding RNA Research;2023-06

5. Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions;Pharmacological Research;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3